Discovery of pyrimidine-tethered benzothiazole derivatives as novel anti-tubercular agents towards multi- and extensively drug resistant Mycobacterium tuberculosis
AbstractIn this study, new benzothiazole–pyrimidine hybrids (5a–c, 6, 7a–f, and 8–15) were designed and synthesised. Two different functionalities on the pyrimidine moiety of lead compound 4 were subjected to a variety of chemical changes with the goal of creating various functionalities and cyclisa...
Main Authors: | Loah R. Hemeda, Mahmoud A. El Hassab, Mohamed A. Abdelgawad, Eman F. Khaleel, Marwa M. Abdel-Aziz, Faizah A. Binjubair, Sara T. Al-Rashood, Wagdy M. Eldehna, Mohamed K. El-Ashrey |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2023.2250575 |
Similar Items
-
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
by: Vadim Makarov, et al.
Published: (2014-03-01) -
Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis
by: Wang Xiang, et al.
Published: (2023-10-01) -
Virtual Screening of Small Molecular Inhibitors against DprE1
by: Gang Zhang, et al.
Published: (2018-02-01) -
An insight into the discovery, clinical studies, compositions, and patents of macozinone: A drug targeting the DprE1 enzyme of Mycobacterium tuberculosis
by: Mohd. Imran, et al.
Published: (2022-10-01) -
Decaprenyl-phosphoryl-ribose 2′-epimerase (DprE1): challenging target for antitubercular drug discovery
by: Jineetkumar Gawad, et al.
Published: (2018-06-01)